ARS Pharmaceuticals
SPRY
SPRY
92 hedge funds and large institutions have $369M invested in ARS Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+3
Holders Change %
+3.37%
% of All Funds
1.45%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
31
Increased
32
Reduced
19
Closed
27
Calls
$7.92M
Puts
$3.22M
Net Calls
+$4.7M
Net Calls Change
-$191K
Top Buyers
| 1 |
1
BlackRock
New York
|
$15.1M |
| 2 |
2
Millennium Management
New York
|
$8.04M |
| 3 |
SCM
3
Sio Capital Management
New York
|
$3.64M |
| 4 |
4
Two Sigma Investments
New York
|
$3.96M |
| 5 |
SAM
5
Sectoral Asset Management
Montreal,
Quebec, Canada
|
$8.41M |
